Hepatitis B vaccines and the thimerosal-autism connection:
One particularly alarming study, published in the journal Neural Development, evaluated the relationship between Thimerosal-containing vaccines and autism diagnoses. Thimerosal, a compound that contains nearly 50% mercury by weight, has been extensively used as a preservative in various vaccines. The study, conducted in two phases, observed a significantly increased risk ratio for the incidence of autism spectrum disorder (ASD) following vaccinations containing Thimerosal. A hypothesis-generating and hypothesis-testing study design confirmed that children exposed to Thimerosal in hepatitis B vaccines had a greater likelihood of developing ASD, highlighting the possible link between Thimerosal exposure and autism.
Speech impairments linked to increase in vaccination rates
Another study, published in the Journal of Toxicology, found a positive and statistically significant association between the proportion of children receiving recommended vaccinations and the prevalence of autism or speech and language impairments (Source 2). The analysis showed that for every 1% increase in vaccination rates, an additional 680 children per state were diagnosed with autism or speech and language impairments. This correlation raises serious concerns about the potential role of vaccines in the development of autism.
Aluminum adjuvant’s connection to brain damage and autism diagnosis
In addition to the possible role of mercury, other studies have pointed to aluminum as a potential culprit. A study published in Journal of Inorganic Biochemistry applied Hill's criteria to investigate whether exposure to aluminum adjuvants in vaccines could contribute to the rising prevalence of autism. The findings showed that countries with the highest exposure to aluminum adjuvants in vaccines also had the highest prevalence of ASD. Furthermore, a significant correlation was found between the amount of aluminum in the vaccines and the current prevalence of ASD in seven Western countries, particularly at the 3-4-month mark, when many vaccines are administered.
MMR antibodies and central nervous system autoimmunity
Moreover, there is evidence suggesting a connection between the measles, mumps, and rubella (MMR) vaccine and autism. A study published in the Journal of Child and Adolescent Psychopharmacology found that autistic children harbored elevated levels of MMR antibodies and had a strong association between MMR antibodies and myelin basic protein (MBP) auto antibodies, which are linked to central nervous system autoimmunity.
Autism more prevalent in certain ethnic groups exposed to Hep B vaccines
The impact of vaccines on male neonates is also of concern. A study published in Neuropsychiatric Disease and Treatment showed that U.S. male neonates vaccinated with the hepatitis B vaccine prior to 1999 had a threefold higher risk for autism diagnosis compared to boys not vaccinated during that period. Moreover, non-white boys were found to be at a greater risk. This suggests that the effects of vaccines on different ethnic groups may vary, and further research is necessary to understand these differences.
Over-vaccination and DNA alterations
The potential link between vaccines and autism has sparked intense debate, with many parents and scientists questioning the safety of the current vaccine schedule. The expression of systemic failure, sensory dysfunction, and autoimmune issues in children diagnosed with regressive autism raises the question of whether these symptoms are the result of subtle DNA alterations caused by the overuse of vaccines, as explained in a study published in the North American Journal of Medical Sciences.
The scientific evidence linking vaccines to autism cannot be ignored. As research continues to emerge, it is becoming increasingly clear that further investigation into the safety and long-term effects of vaccines is critical. The potential risks associated with their ingredients must be thoroughly examined to ensure the well-being of future generations.
Sources include:
Please contact us for more information.
